![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
-Tocopherolquinone by Human NAD(P)H:Quinone
Oxidoreductase: The Role of -Tocopherolhydroquinone as a
Cellular Antioxidant
Department of Pharmaceutical Sciences, School of Pharmacy and
Cancer Center, University of Colorado Health Sciences Center, Denver,
Colorado 80262 (D.S., E.M.B., D.R.), and
Department of Pharmacology and
Toxicology, College of Pharmacy and Cancer Center, University of
Arizona, Tucson, Arizona 85721 (J.A.B., D.C.L.)
-Tocopherolquinone (TQ), a product of -tocopherol oxidation, can
function as an antioxidant after reduction to
-tocopherolhydroquinone (TQH2). We examined the ability
of human NAD(P)H:quinone oxidoreductase (NQO1) to catalyze the
reduction of TQ to TQH2 in cell-free and cellular systems.
In reactions with purified human NQO1, TQ was reduced to
TQH2. Kinetic parameters for the reduction of TQ by NQO1
(Km = 370 µM;
kcat = 5.6 × 103
min
1;
kcat/Km = 15 min1 · µM1) indicate that
NQO1 can efficiently reduce TQ to TQH2. A comparison of the
rate of reduction of TQ and coenzyme Q10 by NQO1
showed that TQ is reduced more efficiently than coenzyme
Q10. Experiments with either Chinese hamster ovary
(CHO) cells stably transfected with human NQO1 or CHO cell sonicates
demonstrated a correlation between NQO1 activity and TQ reduction to
TQH2. CHO cells with elevated NQO1 generated and
maintained higher levels of TQH2 after treatment
with TQ relative to NQO1-deficient CHO cells. TQH2
generated from NQO1-mediated reduction of TQ prevented cumene
hydroperoxide-induced lipid peroxidation in rat liver microsomes. In
addition, cumene hydroperoxide-induced lipid peroxidation was inhibited
more efficiently by TQ in CHO cell lines with elevated NQO1 activity.
These data demonstrate that NQO1 can reduce TQ to
TQH2 and that TQH2 can function
as an efficient antioxidant. This work suggests that one of the
physiological functions of NQO1 may be to regenerate antioxidant forms
of -tocopherol.
This article has been cited by other articles:
|
|
 |
|
  L. M. Aleksunes and J. E. Manautou Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease Toxicol Pathol, June 1, 2007; 35(4): 459 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Han, Y. J. Lee, S. Y. Lee, E. M. Kim, Y. Moon, H. W. Kim, and O. Hwang Protective Effect of Sulforaphane against Dopaminergic Cell Death J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 249 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-L. Levonen, M. Inkala, T. Heikura, S. Jauhiainen, H.-K. Jyrkkanen, E. Kansanen, K. Maatta, E. Romppanen, P. Turunen, J. Rutanen, et al. Nrf2 Gene Transfer Induces Antioxidant Enzymes and Suppresses Smooth Muscle Cell Growth In Vitro and Reduces Oxidative Stress in Rabbit Aorta In Vivo Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 741 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Yates, M. Tauchi, F. Katsuoka, K. C. Flanders, K. T. Liby, T. Honda, G. W. Gribble, D. A. Johnson, J. A. Johnson, N. C. Burton, et al. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol. Cancer Ther., January 1, 2007; 6(1): 154 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Merker, S. H. Audi, R. D. Bongard, B. J. Lindemer, and G. S. Krenz Influence of pulmonary arterial endothelial cells on quinone redox status: effect of hyperoxia-induced NAD(P)H:quinone oxidoreductase 1 Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L607 - L619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ito, H. Nishiyama, J. Watanabe, H. Kawanishi, T. Takahashi, T. Kamoto, T. Habuchi, and O. Ogawa Association of the PIG3 Promoter Polymorphism with Invasive Bladder Cancer in a Japanese Population Jpn. J. Clin. Oncol., February 1, 2006; 36(2): 116 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Lawson, K. Woodson, J. Virtamo, and D. Albanes Association of the NAD(P)H:Quinone Oxidoreductase (NQO1) 609C->T Polymorphism with Lung Cancer Risk among Male Smokers Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2275 - 2276. [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Gonzalez, D. F. Ackerley, S. V. Lynch, and A. Matin ChrR, a Soluble Quinone Reductase of Pseudomonas putida That Defends against H2O2 J. Biol. Chem., June 17, 2005; 280(24): 22590 - 22595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. K. Harvey, S. C. Anderson, and N. SundarRaj Downstream Effects of ROCK Signaling in Cultured Human Corneal Stromal Cells: Microarray Analysis of Gene Expression Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2168 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dhakshinamoorthy and A. G. Porter Nitric Oxide-induced Transcriptional Up-regulation of Protective Genes by Nrf2 via the Antioxidant Response Element Counteracts Apoptosis of Neuroblastoma Cells J. Biol. Chem., May 7, 2004; 279(19): 20096 - 20107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Siegel, D. L. Gustafson, D. L. Dehn, J. Y. Han, P. Boonchoong, L. J. Berliner, and D. Ross NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide Scavenger Mol. Pharmacol., May 1, 2004; 65(5): 1238 - 1247. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. L. David, I. Romieu, J. J. Sienra-Monge, W. J. Collins, M. Ramirez-Aguilar, B. E. del Rio-Navarro, N. I. Reyes-Ruiz, R. W. Morris, J. M. Marzec, and S. J. London Nicotinamide Adenine Dinucleotide (Phosphate) Reduced:Quinone Oxidoreductase and Glutathione S-Transferase M1 Polymorphisms and Childhood Asthma Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1199 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Cullen, M. M. Hinkhouse, M. Grady, A. W. Gaut, J. Liu, Y. P. Zhang, C. J. Darby Weydert, F. E. Domann, and L. W. Oberley Dicumarol Inhibition of NADPH:Quinone Oxidoreductase Induces Growth Inhibition of Pancreatic Cancer via a Superoxide-mediated Mechanism Cancer Res., September 1, 2003; 63(17): 5513 - 5520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Dehn, D. Siegel, E. Swann, C. J. Moody, and D. Ross Biochemical, Cytotoxic, and Genotoxic Effects of ES936, a Mechanism-Based Inhibitor of NAD(P)H:quinone Oxidoreductase 1, in Cellular Systems Mol. Pharmacol., September 1, 2003; 64(3): 714 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Anwar, D. Dehn, D. Siegel, J. K. Kepa, L. J. Tang, J. A. Pietenpol, and D. Ross Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free Systems J. Biol. Chem., March 14, 2003; 278(12): 10368 - 10373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Winski, Y. Koutalos, D. L. Bentley, and D. Ross Subcellular Localization of NAD(P)H:quinone Oxidoreductase 1 in Human Cancer Cells Cancer Res., March 1, 2002; 62(5): 1420 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Talalay and J. W. Fahey Phytochemicals from Cruciferous Plants Protect against Cancer by Modulating Carcinogen Metabolism J. Nutr., November 1, 2001; 131(11): 3027S - 3033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Long II, R. L. Waikel, X.-J. Wang, D. R. Roop, and A. K. Jaiswal NAD(P)H : quinone Oxidoreductase 1 Deficiency and Increased Susceptibility to 7,12-Dimethylbenz[a]-anthracene-Induced Carcinogenesis in Mouse Skin J Natl Cancer Inst, August 1, 2001; 93(15): 1166 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. O'Brien, T. P. Twaroski, M. L. Cunningham, H. P. Glauert, and B. T. Spear Effects of Peroxisome Proliferators on Antioxidant Enzymes and Antioxidant Vitamins in Rats and Hamsters Toxicol. Sci., April 1, 2001; 60(2): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Smith, Y. Wang, E. Kane, S. Rollinson, J. L. Wiemels, E. Roman, P. Roddam, R. Cartwright, and G. Morgan Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults Blood, March 1, 2001; 97(5): 1422 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Siegel, A. Anwar, S. L. Winski, J. K. Kepa, K. L. Zolman, and D. Ross Rapid Polyubiquitination and Proteasomal Degradation of a Mutant Form of NAD(P)H:Quinone Oxidoreductase 1 Mol. Pharmacol., February 1, 2001; 59(2): 263 - 268. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Siemankowski, J. Morreale, B. D. Butts, and M. M. Briehl Increased Tumor Necrosis Factor-{{alpha}} Sensitivity of MCF-7 Cells Transfected with NAD(P)H:Quinone Reductase Cancer Res., July 1, 2000; 60(13): 3638 - 3644. [Abstract] [Full Text]
|
|
|
|
|
|
L. P. Schelonka, D. Siegel, M. W. Wilson, A. Meininger, and D. Ross Immunohistochemical Localization of NQO1 in Epithelial Dysplasia and Neoplasia and in Donor Eyes Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1617 - 1622. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Wiemels, A. Pagnamenta, G. M. Taylor, O. B. Eden, F. E. Alexander, and M. F. Greaves A Lack of a Functional NAD(P)H:Quinone Oxidoreductase Allele Is Selectively Associated with Pediatric Leukemias That Have MLL Fusions Cancer Res., August 1, 1999; 59(16): 4095 - 4099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Smith Benzene, NQO1, and genetic susceptibility to cancer PNAS, July 6, 1999; 96(14): 7624 - 7626. [Full Text] [PDF]
|
|
|
|
|
|
R. I. Bello, C. Gomez-Diaz, F. Navarro, F. J. Alcain, and J. M. Villalba Expression of NAD(P)H:Quinone Oxidoreductase 1 in HeLa Cells. ROLE OF HYDROGEN PEROXIDE AND GROWTH PHASE J. Biol. Chem., November 21, 2001; 276(48): 44379 - 44384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamura, Q. Feng, T. Kumagai, K. Torikai, H. Ohigashi, T. Osawa, N. Noguchi, E. Niki, and K. Uchida Ebselen, a Glutathione Peroxidase Mimetic Seleno-organic Compound, as a Multifunctional Antioxidant. IMPLICATION FOR INFLAMMATION-ASSOCIATED CARCINOGENESIS J. Biol. Chem., January 18, 2002; 277(4): 2687 - 2694. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
